Partner Content Partner Content U.S. Upper Limb Prosthetics Market will touch $544 million b... Upper Limb Prosthetics Market will cross $2.3bn by 2025
News Regeneron gets long-awaited FDA okay for myeloma drug Regeneron's bid to join the crowded US market for BCMA-targeted bispecific antibodies for multiple myeloma has finally been realised.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
